Genomate
Cambridge, US · Founded 2022 · 1 known investors
Find your way into Genomate
45 people in our graph share verified history with the Genomate team — schools, employers, funds. One of them is your warm intro.
Stefano Galiassounlockedknows ISTVAN PETAK · together at University of Illinois Chicago (overlapped)
×2knows the team · via Harvard Medical School
×8knows the team · via University of Illinois Chicago
knows the team · via Semmelweis University
Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.
Founders & leadership
Genomate was founded in 2022 by ISTVAN PETAK.
IP
ISTVAN PETAKinFounder and Chief Scientific OfficerIstvan Petak is a physician-scientist with over 30 years of experience in precision oncology. He co-founded Oncompass Medicine in 2008 to advance next-generation sequencing adoption in oncology, and founded Genomate Health in 2022 to develop AI-driven computational systems for analyzing complex tumor profiles and treatment selection.
Board
JS
JARED SCHRIEBERBoard director
SF
SCOTT FRIEDMANBoard director
LM
LASZLO MECHTLERBoard director
RS
RICHARD SCHWABBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$10.4M disclosed across 3 rounds · 2022–2025
▶$2MraisedMar 2025 · 1 investors · Other Health CareRule 506(b)
▶$2MraisedMar 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- RICHARD SCHWABDirector
- JARED SCHRIEBERDirector
- ISTVAN PETAKExecutive Officer, Director
- SCOTT FRIEDMANDirector
- LASZLO MECHTLERDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Mar 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$5.7MraisedFeb 2025 · 7 investors · Other Health CareRule 506(b)
▶$5.7MraisedFeb 2025 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- SCOTT FRIEDMANDirector
- RICHARD SCHWABDirector
- LASZLO MECHTLERDirector
- JARED SCHRIEBERDirector
- ISTVAN PETAKExecutive Officer, Director
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$2.6MraisedFeb 2025 · 4 investors · Other Health CareRule 506(b)
▶$2.6MraisedFeb 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- ISTVAN PETAKExecutive Officer, Director
- JARED SCHRIEBERDirector
- SCOTT FRIEDMANDirector
- LASZLO MECHTLERDirector
- RICHARD SCHWABDirector
- Offering amount
- $2.6M
- Amount sold
- $2.6M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Foundation Medicine13 shared keywordsFoundation Medicine is a precision medicine company that develops comprehensive genomic profiling and companion diagnostic tests for cancer and other diseases. It serves patients, healthcare providers, and biopharma companies, with tests available across all U.S. states and 45+ countries.
Thumbnail for Seragon Pharmaceuticals9 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.
Companies competing with Genomate for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Genomate do?
- Genomate Health develops an AI-powered clinical decision support system for precision oncology that analyzes a patient's molecular profile to produce evidence-based treatment rankings for physicians. Its Genomate platform combines oncology, genomics, and computational reasoning to support personalized cancer treatment decisions.
- Who founded Genomate?
- Genomate was founded by ISTVAN PETAK in 2022.
- Who are Genomate's investors?
- Genomate's investors include Oktogon Ventures.
- How much funding has Genomate raised?
- Genomate has disclosed $10.4M raised across 3 rounds.
- Where is Genomate headquartered?
- Genomate is headquartered in Cambridge, US.